Literature DB >> 17410559

Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations.

D Speake1, D G Evans, F Lalloo, N A Scott, J Hill.   

Abstract

BACKGROUND: :The aim of this study was to determine the proportion of patients with familial adenomatous polyposis (FAP) who had mutations in the desmoid region of the adenomatous polyposis coli (APC) gene that phenotypically expresses desmoid disease, and to determine the role for surgery in these patients.
METHODS: Data from the North West Region FAP database and case notes were analysed retrospectively.
RESULTS: Of 363 patients with FAP, 47 from ten families had APC mutations in the desmoid region 3' to codon 1399. Of 22 patients undergoing surgery, 16 developed desmoids, and of these 12 had mesenteric desmoid disease. Complications from mesenteric desmoids were death (two patients), enterectomy (three), local resection (three), fistula (one), cholangitis and local resection (one), bowel obstruction (one) and bowel and ureteric obstruction (one). Preoperative polyp burden ranged from 0 to 100 in eight patients (median age 24.5 (range 16-39) years) and more than 100 in seven (median age 39 (range 31-64) years). One patient had no record of polyp burden.
CONCLUSION: In individuals with 3' APC mutations, abdominal surgery is associated with a 65 per cent risk of developing mesenteric desmoids. An alternative strategy might be to attempt to manage the polyps endoscopically. Copyright (c) 2007 British Journal of Surgery Society Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17410559     DOI: 10.1002/bjs.5633

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Successful treatment of an intra-abdominal desmoid tumor with irinotecan, fluorouracil, and leucovorin plus bevacizumab in a patient with familial adenomatous polyposis.

Authors:  Leonardo Atem Costa; Loureno Cezana; Thiago Bueno Oliveira; Aldo Lourenço Dettino; Maria Dirlei Begnami; Clovis Antônio Pinto; Marcello Ferretti Fanelli; Celso Abdon Mello
Journal:  Int J Colorectal Dis       Date:  2011-04-30       Impact factor: 2.571

2.  Desmoid tumour in familial adenomatous polyposis patients: responses to treatments.

Authors:  Thibault Desurmont; Jérémie H Lefèvre; Conor Shields; Chrystelle Colas; Emmanuel Tiret; Yann Parc
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

Review 3.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version).

Authors:  Hideyuki Ishida; Tatsuro Yamaguchi; Kohji Tanakaya; Kiwamu Akagi; Yasuhiro Inoue; Kensuke Kumamoto; Hideki Shimodaira; Shigeki Sekine; Toshiaki Tanaka; Akiko Chino; Naohiro Tomita; Takeshi Nakajima; Hirotoshi Hasegawa; Takao Hinoi; Akira Hirasawa; Yasuyuki Miyakura; Yoshie Murakami; Kei Muro; Yoichi Ajioka; Yojiro Hashiguchi; Yoshinori Ito; Yutaka Saito; Tetsuya Hamaguchi; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Hiroshi Kawano; Yusuke Kinugasa; Norihiro Kokudo; Keiko Murofushi; Takako Nakajima; Shiro Oka; Yoshiharu Sakai; Akihiko Tsuji; Keisuke Uehara; Hideki Ueno; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Michio Itabashi; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Yasuhiro Shimada; Keiichi Takahashi; Shinji Tanaka; Osamu Tsuruta; Toshiharu Yamaguchi; Kenichi Sugihara; Toshiaki Watanabe
Journal:  J Anus Rectum Colon       Date:  2018-05-25

Review 4.  Hereditary and familial colon cancer.

Authors:  Kory W Jasperson; Thérèse M Tuohy; Deborah W Neklason; Randall W Burt
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

Review 5.  Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations.

Authors:  Fábio Guilherme Campos
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

6.  Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis.

Authors:  Fábio Guilherme Campos; Carlos Augusto Real Martinez; Marleny Novaes; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

7.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Authors:  Naohiro Tomita; Hideyuki Ishida; Kohji Tanakaya; Tatsuro Yamaguchi; Kensuke Kumamoto; Toshiaki Tanaka; Takao Hinoi; Yasuyuki Miyakura; Hirotoshi Hasegawa; Tetsuji Takayama; Hideki Ishikawa; Takeshi Nakajima; Akiko Chino; Hideki Shimodaira; Akira Hirasawa; Yoshiko Nakayama; Shigeki Sekine; Kazuo Tamura; Kiwamu Akagi; Yuko Kawasaki; Hirotoshi Kobayashi; Masami Arai; Michio Itabashi; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

8.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Authors:  Kevin J Monahan; Nicola Bradshaw; Sunil Dolwani; Bianca Desouza; Malcolm G Dunlop; James E East; Mohammad Ilyas; Asha Kaur; Fiona Lalloo; Andrew Latchford; Matthew D Rutter; Ian Tomlinson; Huw J W Thomas; James Hill
Journal:  Gut       Date:  2019-11-28       Impact factor: 23.059

9.  Clinical characteristics and adequate treatment of familial adenomatous polyposis combined with desmoid tumors.

Authors:  Won Beom Jung; Chan Wook Kim; Jin Cheon Kim
Journal:  Cancer Res Treat       Date:  2014-08-25       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.